Efficacy and safety of Xuesaitong soft capsule plus antiplatelet agents in ischemic stroke patients: a large-scale, multicenter, controlled, retrospective real-world study
Haiqing Song, Yanjie Gao, Yuan Tang, Xinghui Gao, Longfei Wu, Li Li, Quanxi Ge, Zhigang Chen, Ting He · 2026
Read Efficacy and safety of Xuesaitong soft capsule plus antiplatelet agents in ischemic stroke patients: a large-scale, multicenter, controlled, retrospective real-world study by Haiqing Song, Yanjie Gao, Yuan Tang, Xinghui Gao, Longfei Wu, Li Li, Quanxi Ge, Zhigang Chen, Ting He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13582177.txt.
Description
Haiqing Song and co-authors test a plant-based capsule added to standard stroke drugs in a 2026 real-world study. The capsule, Xuesaitong, comes from a ginseng-like herb used in China. Lab work hinted the pair works better than blood thinners alone, but large clinic proof was thin.
Records covered close to thirty-nine thousand stroke patients at many centers. About fourteen hundred took the capsule plus standard drugs; the rest took standard drugs alone. After matching like with like, the capsule group had fewer major heart and brain events at one year. The same gap held at two and three years. The study tracks safety too, giving doctors real-world data on a widely used add-on.
Catalog record
| CREATOR | Haiqing Song, Yanjie Gao, Yuan Tang, Xinghui Gao, Longfei Wu, Li Li, Quanxi Ge, Zhigang Chen, Ting He |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |